Interleukin-2 receptor can predict cancer outcome

High serum concentrations of the alpha chain IL-2 receptor are highly correlated with a shorter survival of patients diagnosed with head and neck squamous-cell carcinoma.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Clinical variables provide little information about the potential of a tumour to spread and consequently the search for effective serum marker molecules has been intense. In 21 April Lancet Eric Tartour and colleagues from the Hôpital Européen Georges Pompidou, Paris, propose the use of soluble interleukin-2 receptor as a prognostic marker in head and neck cancer.

The alpha chain of the IL-2 receptor (IL-2R*) is expressed on activated T cells and at lower levels on activated B cells, natural killer cells, and tumour cells. Tartour et al performed a multivariate prospective analysis of 234 patients with head and neck squamous-cell carcinoma and found that high serum concentrations of sIL-2R* at diagnosis was highly correlated with a shorter survival (p<0·0001). In addition, patients with low serum sIL-2R* at diagnosis were less likely to develop metastasis during the subsequent 36 months, compared with the group with high serum sIL-2R* (p<0·001) (Lancet 2001, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours